EmGenisys logo — Breeding Something Epic

EmGenisys

Breeding Something Epic

Founded 2019 United States Houston, United States 6 employees Seed Total: $2.00M Agriculture, Biotechnology +3

General Information

Company Name EmGenisys
Founded Year 2019
Location United States Houston, United States +1
Employees 6
Industries Agriculture, Biotechnology, Health Care +2
Funding Stage Seed
Social

Get notified when EmGenisys moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EmGenisys

EmGenisys, founded in 2019 and headquartered in the United States, operates at the intersection of Agriculture, Biotechnology, and AgriTech. The company is dedicated to enhancing livestock production through innovative technology. Its flagship product is a SaaS solution that offers a noninvasive analysis of embryo morphokinetic activity, aimed at improving pregnancy outcomes via assisted reproductive techniques.

With a motto of "Breeding Something Epic," EmGenisys stands out for its unique approach to advancing health care in the agricultural sector. Although their last recorded investment was a modest $4.00K Grant from Texas A&M Innovation on 19 May 2022, the company shows promise in a niche that is becoming increasingly important.

EmGenisys's focus on life sciences and health care within agriculture positions it well to tap into broader trends seeking sustainable or technologically enhanced agricultural solutions.

Taxonomy: reproductive advancements, embryo health assessment, sustainable production, animal welfare, precision technology, video motion magnification, embryo viability, sex determination, animal production improvement, reproductive technologies, animal science, embryology, bovine reproduction, equine reproduction

Services & Products

Data-driven Embryo Analysis
Embryo Health Evaluation
Machine Learning Platform for Embryo Selection

Target Customers

Animal Producers Livestock Farmers Agricultural Industry Veterinarians

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• 3
Investor Investor
•••• ••••
01 Jul 2025
Grant •••••• 1
Investor
01 Sep 2024
Grant •••••• 2
Investor
•••• ••••
01 Jun 2022

EmGenisys Alternatives & Competitors

EmGenisys vs

Your complete source for artificial breeding and embryo transfer supplies.

1 employees
Food and Beverage, Manufacturing
EmGenisys vs
Vytelle
Vytelle United States

The most accessible, reliable and predictable solution to drive sustainable genetic progress.

Series B
104 employees
Agriculture, Biotechnology
EmGenisys vs
Trans Ova Genetics
Trans Ova Genetics United States

Multiply Success

250 employees
Biotechnology, Health Care

FAQ About EmGenisys

Breeding Something Epic
EmGenisys was founded in 2019.
EmGenisys is headquartered in Houston, United States.
EmGenisys operates in the following industries: Agriculture, Biotechnology, Health Care, Life Sciences, AgriTech.
EmGenisys has approximately 6 employees.
EmGenisys has completed 3 funding rounds, raising a total of $2.00M. The latest funding stage is Seed.
EmGenisys offers: Data-driven Embryo Analysis, Embryo Health Evaluation, Machine Learning Platform for Embryo Selection.
Top alternatives and competitors to EmGenisys include Reproduction Provisions & Resources, Vytelle, Trans Ova Genetics, Verility, Inc., FIVMadrid. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EmGenisys and Reproduction Provisions & Resources are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EmGenisys and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes